Laboratory diagnosis of viral hepatitis

Infectious Disease Clinics of North America

Volumn 15, Issue 4, 2001, Pages 1109-1126

  Wolk, Donna M ^a,b   Jones, Mary F ^a,b   Rosenblatt, Jon E ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS E VIRUS; LABORATORY DIAGNOSIS; REVIEW; VIRUS HEPATITIS; VIRUS LOAD;

EID: 0035216138     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70188-4     Document Type: Article

References (34)

1. Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory
2. Hepatitis E: An overview and recent advances in clinical and laboratory research
3. Epidemiology of hepatitis C
4. Emerging and other communicable diseases (EMC)
5. Serological response to the hepatitis delta virus in hepatitis D
6. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes
7. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy
8. Hepatitis A: Old and new
9. Interferon alfa- 2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group
10. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients
11. Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant
12. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests
13. Molecular diagnosis of hepatitis C
14. Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications
15. Diagnostic tests for hepatitis C
16. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 3, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method
17. Hepatitis C virus quantitation: Optimization of strategies for detecting low-level viremia
18. Hepatitis B and D viruses
19. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations
20. The persistence of hepatitis A IgM antibody after acute clinical hepatitis A
21. Evaluation of a new assay for HBV-DNA quantitation in patients with chronic hepatitis B
22. Acute hepatitis E by a new isolate acquired in the United States
23. Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA
24. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine
25. Viral hepatitis: How to manage type C and D infections
26. A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards
27. Diagnostic tests for hepatitis C
28. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays
29. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States
30. Host immune response to hepatitis A virus
31. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses
32. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy
33. Current topics in hepatitis B